Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients
M Sun, H Lai, J Huang, J Liu, Y Li, J Tian… - Journal of …, 2023 - academic.oup.com
Background Molnupiravir has been considered a promising candidate for COVID-19. Its
efficacy and safety in non-severe COVID-19 patients and the differences between patients …
efficacy and safety in non-severe COVID-19 patients and the differences between patients …
Outpatient treatment of confirmed COVID-19: a living, rapid evidence review for the American College of Physicians (Version 2)
Background: Clinicians and patients want to know the benefits and harms of outpatient
treatment options for the Omicron variant of SARS-CoV-2. Purpose: To assess the benefits …
treatment options for the Omicron variant of SARS-CoV-2. Purpose: To assess the benefits …
Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians
A Qaseem, V Snow, JT Cross Jr… - Annals of internal …, 2008 - acpjournals.org
Description: The American College of Physicians and American Academy of Family
Physicians developed this guideline to present the available evidence on current …
Physicians developed this guideline to present the available evidence on current …
Outpatient treatment of confirmed COVID-19: living, rapid practice points from the American College of Physicians (version 1)
A Qaseem, J Yost, MC Miller, R Andrews… - Annals of Internal …, 2023 - acpjournals.org
An updated version of this article was published on 19 September 2023. Description:
Strategies to manage COVID-19 in the outpatient setting continue to evolve as new data …
Strategies to manage COVID-19 in the outpatient setting continue to evolve as new data …
Sensitivity and Specificity of Using GPT-3.5 Turbo Models for Title and Abstract Screening in Systematic Reviews and Meta-analyses
Background: Systematic reviews are performed manually despite the exponential growth of
scientific literature. Objective: To investigate the sensitivity and specificity of GPT-3.5 Turbo …
scientific literature. Objective: To investigate the sensitivity and specificity of GPT-3.5 Turbo …
Ongoing need for clinical trials and contemporary end points for outpatient COVID-19
TC Lee, DR Boulware - Annals of internal medicine, 2023 - acpjournals.org
The ACP presents recommendations for outpatient treatment of COVID-19 based on
Sommer and colleagues' systematic review. The editorialists commend the authors of the …
Sommer and colleagues' systematic review. The editorialists commend the authors of the …
Outpatient treatment of confirmed COVID-19: living, rapid practice points from the American College of Physicians (version 2)
A Qaseem, J Yost, GM Abraham… - Annals of Internal …, 2023 - acpjournals.org
Description: Evidence for the use of outpatient treatments in adults with confirmed COVID-19
continues to evolve with new data. This is version 2 of the American College of Physicians …
continues to evolve with new data. This is version 2 of the American College of Physicians …
Nirmatrelvir/ritonavir for COVID-19: an overview of systematic reviews
M Cruciani, I Pati, F Masiello, S Pupella… - Journal of …, 2024 - academic.oup.com
Objectives A reappraisal of the validity of the conclusions of systematic reviews (SRs)
related to nirmatrelvir/ritonavir for the treatment of COVID-19. Methods An overview of SRs …
related to nirmatrelvir/ritonavir for the treatment of COVID-19. Methods An overview of SRs …
Sensitivity, specificity and avoidable workload of using a large language models for title and abstract screening in systematic reviews and meta-analyses
Importance: Systematic reviews are time-consuming and are still performed predominately
manually by researchers despite the exponential growth of scientific literature. Objective: To …
manually by researchers despite the exponential growth of scientific literature. Objective: To …
Unlocking the therapeutic potential of edible mushrooms: Ganoderma and their secondary metabolites as novel antiviral agents for combating COVID-19
SC Karunarathna, W Lu, N Patabedige… - New Zealand Journal …, 2024 - Taylor & Francis
The global COVID-19 pandemic, caused by SARS-CoV-2, has created an urgent need for
novel antiviral agents, as it has led to a devastating loss of lives worldwide. In response …
novel antiviral agents, as it has led to a devastating loss of lives worldwide. In response …